Save your place

Sign in to WhoBought

Please try again later.

Invesco's Applied Therapeutics, Inc. (APLT) position

Not anymore: Invesco fully exited APLT in Q2 2025. The position peaked at an amount we cannot price in Q1 2024.
View full portfolio →
Value at exit
an amount we cannot price
Shares at exit
51K
Quarter-end price
No quarter-end price available

Average buy price is hidden here because at least one covered purchase quarter has no usable local mean price.

APLT price vs Invesco's position

Dates
Average closing price · filing quarter
Price range · filing quarter

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q2 2025 Exited −51K −100.0% 0 Aug 13, 2025
Q1 2025 Reduced −2K −4.5% 51K May 12, 2025
Q4 2024 Reduced −506K −90.4% 53K Feb 13, 2025
Q3 2024 Added +514K +1,136.4% 560K Nov 12, 2024
Q2 2024 Reduced −495K −91.6% 45K Aug 13, 2024
Q1 2024 New +540K 540K May 14, 2024
Data through Q2 2025 · filed Aug 13, 2025
6 grouped rows from 6 quarters

More Invesco positions

Common questions

Does Invesco own APLT?

Not currently. Invesco fully exited APLT in Q2 2025, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Invesco buy APLT?

Invesco first disclosed a APLT position in Q1 2024; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Invesco sell APLT?

Yes. Invesco reduced and then fully exited APLT by Q2 2025; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of APLT does Invesco own?

None as of the latest filing: Invesco has exited APLT. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Invesco pay for APLT?

Invesco began building the APLT position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.